TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2177-2185

  Dyer, Douglas P ^a,b   Thomson, Jennifer M ^a   Hermant, Aurelie ^c   Jowitt, Thomas A ^a,d   Handel, Tracy M ^b   Proudfoot, Amanda E I ^c   Day, Anthony J ^a,d   Milner, Caroline M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c MERCK SERONO S A   (Switzerland)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOSAMINOGLYCAN; HEPARIN; INTEGRIN; INTERLEUKIN 8; TNF STIMULATED GENE PROTEIN 6; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE MIGRATION INHIBITION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ALLOGRAFTS; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; HEPARIN; HL-60 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-8; NEUTROPHILS; STEM CELL TRANSPLANTATION;

EID: 84896536949     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300194     Document Type: Article

References (57)

1. Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678-689.
2. Smith,W. B., J. R. Gamble, I. Clark-Lewis, and M. A. Vadas. 1991. Interleukin-8 induces neutrophil transendothelial migration. Immunology 72: 65-72.
3. Hillyer, P., E. Mordelet, G. Flynn, and D. Male. 2003. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin. Exp. Immunol. 134: 431-441.
4. Lisignoli, G., S. Toneguzzi, C. Pozzi, A. Piacentini, M. Riccio, A. Ferruzzi, G. Gualtieri, and A. Facchini. 1999. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J. Rheumatol. 26: 791-799.
5. Kuschert, G. S., A. J. Hoogewerf, A. E. Proudfoot, C. W. Chung, R. M. Cooke, R. E. Hubbard, T. N. Wells, and P. N. Sanderson. 1998. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37: 11193-11201.
6. Webb, L. M., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90: 7158-7162.
7. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore, C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91: 385-395.
8. Frevert, C. W., M. G. Kinsella, C. Vathanaprida, R. B. Goodman, D. G. Baskin, A. Proudfoot, T. N. Wells, T. N. Wight, and T. R. Martin. 2003. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am. J. Respir. Cell Mol. Biol. 28: 464-472.
9. Lee, J., R. Horuk, G. C. Rice, G. L. Bennett, T. Camerato, and W. I. Wood. 1992. Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem. 267: 16283-16287.
10. Das, S. T., L. Rajagopalan, A. Guerrero-Plata, J. Sai, A. Richmond, R. P. Garofalo, and K. Rajarathnam. 2010. Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. PLoS ONE 5: e11754.
11. Wang, L., M. Fuster, P. Sriramarao, and J. D. Esko. 2005. Endothelial heparan sulfate deficiency impairs L-selectin-And chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6: 902-910.
12. Colditz, I. G., M. A. Schneider, M. Pruenster, and A. Rot. 2007. Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb. Haemost. 97: 688-693.
13. Gangavarapu, P., L. Rajagopalan, D. Kolli, A. Guerrero-Plata, R. P. Garofalo, and K. Rajarathnam. 2012. The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment. J. Leukoc. Biol. 91: 259-265.
14. Lee, T. H., H. G. Wisniewski, and J. Vilcek. 1992. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell Biol. 116: 545-557.
15. Mahoney, D. J., C. Swales, N. A. Athanasou, M. Bombardieri, C. Pitzalis, K. Kliskey, M. Sharif, A. J. Day, C. M. Milner, and A. Sabokbar. 2011. TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. Arthritis Rheum. 63: 1034-1043.
16. Nagyeri, G., M. Radacs, S. Ghassemi-Nejad, B. Tryniszewska, K. Olasz, G. Hutas, Z. Gyorfy, V. C. Hascall, T. T. Glant, and K. Mikecz. 2011. TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin. J. Biol. Chem. 286: 23559-23569.
17. Getting, S. J., D. J. Mahoney, T. Cao, M. S. Rugg, E. Fries, C. M. Milner, M. Perretti, and A. J. Day. 2002. The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan-And inter-A-inhibitor-independent manner. J. Biol. Chem. 277: 51068-51076.
18. Milner, C. M., and A. J. Day. 2003. TSG-6: a multifunctional protein associated with inflammation. J. Cell Sci. 116: 1863-1873.
19. Cao, T. V., M. La, S. J. Getting, A. J. Day, and M. Perretti. 2004. Inhibitory effects of TSG-6 Link module on leukocyte-endothelial cell interactions in vitro and in vivo. Microcirculation 11: 615-624.
20. Szántó, S., T. Bárdos, I. Gál, T. T. Glant, and K. Mikecz. 2004. Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice. Arthritis Rheum. 50: 3012-3022.
21. Lee, R. H., A. A. Pulin, M. J. Seo, D. J. Kota, J. Ylostalo, B. L. Larson, L. Semprun-Prieto, P. Delafontaine, and D. J. Prockop. 2009. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63.
22. Oh, J. Y., G. W. Roddy, H. Choi, R. H. Lee, J. H. Ylöstalo, R. H. Rosa, Jr., and D. J. Prockop. 2010. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc. Natl. Acad. Sci. USA 107: 16875-16880.
23. Choi, H., R. H. Lee, N. Bazhanov, J. Y. Oh, and D. J. Prockop. 2011. Antiinflammatory protein TSG-6 secreted by activated MSCs attenuates zymosaninduced mouse peritonitis by decreasing TLR2/NF-kB signaling in resident macrophages. Blood 118: 330-338.
24. Oh, J. Y., R. H. Lee, J. M. Yu, J. H. Ko, H. J. Lee, A. Y. Ko, G. W. Roddy, and D. J. Prockop. 2012. Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol. Ther. 20: 2143-2152.
25. Maina, V., A. Cotena, A. Doni, M. Nebuloni, F. Pasqualini, C. M. Milner, A. J. Day, A. Mantovani, and C. Garlanda. 2009. Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. J. Leukoc. Biol. 86: 123-132.
26. Chang, M. Y., C. K. Chan, K. R. Braun, P. S. Green, K. D. O'Brien, A. Chait, A. J. Day, and T. N. Wight. 2012. Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix. J. Biol. Chem. 287: 14122-14135.
27. Mahoney, D. J., B. Mulloy, M. J. Forster, C. D. Blundell, E. Fries, C. M. Milner, and A. J. Day. 2005. Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments. J. Biol. Chem. 280: 27044-27055.
28. Kuznetsova, S. A., A. J. Day, D. J. Mahoney, M. S. Rugg, D. F. Mosher, and D. D. Roberts. 2005. The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-A-trypsin inhibitor. J. Biol. Chem. 280: 30899-30908.
29. Parkar, A. A., and A. J. Day. 1997. Overlapping sites on the Link module of human TSG-6 mediate binding to hyaluronan and chrondroitin-4-sulphate. FEBS Lett. 410: 413-417.
30. Marson, A., D. E. Robinson, P. N. Brookes, B. Mulloy, M. Wiles, S. J. Clark, H. L. Fielder, L. J. Collinson, S. A. Cain, C. M. Kielty, et al. 2009. Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions. Glycobiology 19: 1537-1546.
31. Nentwich, H. A., Z. Mustafa, M. S. Rugg, B. D. Marsden, M. R. Cordell, D. J. Mahoney, S. C. Jenkins, B. Dowling, E. Fries, C. M. Milner, et al. 2002. A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module. Chromosomal localization, frequency analysis, modeling, and expression. J. Biol. Chem. 277: 15354-15362.
32. Tanino, Y., D. R. Coombe, S. E. Gill, W. C. Kett, O. Kajikawa, A. E. Proudfoot, T. N. Wells, W. C. Parks, T. N. Wight, T. R. Martin, and C. W. Frevert. 2010. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J. Immunol. 184: 2677-2685.
33. Clark, S. J., V. A. Higman, B. Mulloy, S. J. Perkins, S. M. Lea, R. B. Sim, and A. J. Day. 2006. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the nondisease-Associated form. J. Biol. Chem. 281: 24713-24720.
34. Jacob, C., M. Leport, C. Szilagyi, J. M. Allen, C. Bertrand, and V. Lagente. 2002. DMSO-treated HL60 cells: a model of neutrophil-like cells mainly expressing PDE4B subtype. Int. Immunopharmacol. 2: 1647-1656.
35. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184: 963-969.
36. Proudfoot, A. E., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N. Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100: 1885-1890.
37. Pruenster, M., L. Mudde, P. Bombosi, S. Dimitrova, M. Zsak, J. Middleton, A. Richmond, G. J. Graham, S. Segerer, R. J. Nibbs, and A. Rot. 2009. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat. Immunol. 10: 101-108.
38. Allen, S. J., D. J. Hamel, and T. M. Handel. 2011. A rapid and efficient way to obtain modified chemokines for functional and biophysical studies. Cytokine 55: 168-173.
39. Biacore. 1997. BIAevaluation Software Handbook Version 3.0. Biacore AB, Uppsala, Sweden.
40. O'Shannessy, D. J., M. Brigham-Burke, and K. Peck. 1992. Immobilization chemistries suitable for use in the BIAcore surface plasmon resonance detector. Anal. Biochem. 205: 132-136.
41. Mahoney, D. J., C. D. Blundell, and A. J. Day. 2001. Mapping the hyaluronanbinding site on the link module from human tumor necrosis factor-stimulated gene-6 by site-directed mutagenesis. J. Biol. Chem. 276: 22764-22771.
42. Park, C. J., N. P. Gabrielson, D. W. Pack, R. D. Jamison, and A. J. Wagoner Johnson. 2009. The effect of chitosan on the migration of neutrophil-like HL60 cells, mediated by IL-8. Biomaterials 30: 436-444.
43. Blundell, C. D., D. J. Mahoney, M. R. Cordell, A. Almond, J. D. Kahmann, A. Perczel, J. D. Taylor, I. D. Campbell, and A. J. Day. 2007. Determining the molecular basis for the pH-dependent interaction between the link module of human TSG-6 and hyaluronan. J. Biol. Chem. 282: 12976-12988.
44. Handel, T. M., Z. Johnson, S. E. Crown, E. K. Lau, and A. E. Proudfoot. 2005. Regulation of protein function by glycosaminoglycans: as exemplified by chemokines. Annu. Rev. Biochem. 74: 385-410.
45. Clore, G. M., E. Appella, M. Yamada, K. Matsushima, and A. M. Gronenborn. 1990. Three-dimensional structure of interleukin 8 in solution. Biochemistry 29: 1689-1696.
46. Richardson, R. M., R. J. Marjoram, L. S. Barak, and R. Snyderman. 2003. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.
47. Middleton, J., A. M. Patterson, L. Gardner, C. Schmutz, and B. A. Ashton. 2002. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100: 3853-3860.
48. Lee, J. S., C. W. Frevert,M. M. Wurfel, S. C. Peiper, V. A.Wong, K. K. Ballman, J. T. Ruzinski, J. S. Rhim, T. R. Martin, and R. B. Goodman. 2003. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J. Immunol. 170: 5244-5251.
49. Lee, J. S., M. M. Wurfel, G. Matute-Bello, C. W. Frevert, M. R. Rosengart, M. Ranganathan, V. W. Wong, T. Holden, S. Sutlief, A. Richmond, et al. 2006. The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. J. Immunol. 177: 8086-8094.
50. Paolini, J. F., D. Willard, T. Consler, M. Luther, and M. S. Krangel. 1994. The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J. Immunol. 153: 2704-2717.
51. Baranova, N. S., E. Nilebäck, F. M. Haller, D. C. Briggs, S. Svedhem, A. J. Day, and R. P. Richter. 2011. The inflammation-Associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers. J. Biol. Chem. 286: 25675-25686.
52. Citro, A., E. Cantarelli, P. Maffi, R. Nano, R. Melzi, A. Mercalli, E. Dugnani, V. Sordi, P. Magistretti, L. Daffonchio, et al. 2012. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J. Clin. Invest. 122: 3647-3651.
53. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3: 36-50.
54. Smith, P., R. E. Fallon, N. E. Mangan, C. M. Walsh, M. Saraiva, J. R. Sayers, A. N. McKenzie, A. Alcami, and P. G. Fallon. 2005. Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J. Exp. Med. 202: 1319-1325.
55. Déruaz, M., A. Frauenschuh, A. L. Alessandri, J. M. Dias, F. M. Coelho, R. C. Russo, B. R. Ferreira, G. J. Graham, J. P. Shaw, T. N. Wells, et al. 2008. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J. Exp. Med. 205: 2019-2031.
56. Fallon, P. G., and A. Alcami. 2006. Pathogen-derived immunomodulatory molecules: future immunotherapeutics? Trends Immunol. 27: 470-476.
57. Montecucco, F., S. Lenglet, V. Braunersreuther, G. Pelli, C. Pellieux, C. Montessuit, R. Lerch, M. Deruaz, A. E. Proudfoot, and F. Mach. 2010. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. Arterioscler. Thromb. Vasc. Biol. 30: 1371-1377.